019736 S70 M5 vr mqr 10214 att03

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

6

Download PDF ↗ Live URL (may be dead)

Document text

PF-07302048 : QCS Infection Ratio Data Listing
VR-MQR- 10214-ATT03, Ver. 1.0
PFIZER CONFID ENTIAL
Page 1
Title: QCS I nfection Ratio Data L isting
Study Number: N/A
Parent Compound Number(s): PF-07302048
Alternative Compound Identifiers: N/A
Pfizer Vaccine Research and Development
401 N. Middletown Rd.
Pearl River, NY
090177e19474664e\Approved\Approved On: 28-Jul-2020 14:01 (GMT)
FDA-CBER-2021-5683-1072932
PF-07302048 : QCS Infection Ratio Data Listing
VR-MQR- 10214-ATT03, Ver. 1.0
PFIZER CONFID ENTIAL
Page 2TABLE OF CONTENTS
LIST OF TABLES ................................ ................................ ................................ ..................... 2
LIST OF TABLES
Table 1. QCS I nfection Ratio Data L isting ................................ ............................... 3
090177e19474664e\Approved\Approved On: 28-Jul-2020 14:01 (GMT)
FDA-CBER-2021-5683-1072933
PF-07302048 : QCS Infection Ratio Data Listing
VR-MQR- 10214-ATT03, Ver. 1.0
PFIZER CONFID ENTIAL
Page 3Table 1. QCS Infection Ratio Data Listing
Date QCS/PlateInfection
Ratio
090177e19474664e\Approved\Approved On: 28-Jul-2020 14:01 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072934
PF-07302048 : QCS Infection Ratio Data Listing
VR-MQR- 10214-ATT03, Ver. 1.0
PFIZER CONFID ENTIAL
Page 4Table 1. QCS Infection Ratio Data Listing
Date QCS/PlateInfection
Ratio
090177e19474664e\Approved\Approved On: 28-Jul-2020 14:01 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072935
PF-07302048 : QCS Infection Ratio Data Listing
VR-MQR- 10214-ATT03, Ver. 1.0
PFIZER CONFID ENTIAL
Page 5Table 1. QCS Infection Ratio Data Listing
Date QCS/PlateInfection
Ratio
090177e19474664e\Approved\Approved On: 28-Jul-2020 14:01 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072936
PF-07302048 : QCS Infection Ratio Data Listing
VR-MQR- 10214-ATT03, Ver. 1.0
PFIZER CONFID ENTIAL
Page 6Table 1. QCS Infection Ratio Data Listing
Date QCS/PlateInfection
Ratio
090177e19474664e\Approved\Approved On: 28-Jul-2020 14:01 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072937